Novugen Pharma US

Novugen is a leading pharmaceutical company specializing in niche, technology-intensive, first-to-market innovative generics and oncology medicines that meet stringent global quality standards.

Our vertically integrated structure seamlessly integrates API and Finished Product R&D, advanced manufacturing, and commercialization—enabling full control across the pharmaceutical value chain from development to market.

Driven by a globally minded strategy, synergistic approach, and deep technical expertise, we develop and supply high-barrier pharmaceutical products while maintaining affordability, quality, and regulatory excellence. Our expanding portfolio of over 280 products across 13 countries reflects our commitment to delivering complex, difficult-to-source medicines across international markets.

With a rapidly growing presence across the United States, ASEAN, MENA, and LATAM regions, Novugen continues to provide life-changing healthcare solutions through scientific innovation, manufacturing excellence, and strategic partnerships—challenging the status quo by accelerating early access to affordable, high-quality medicines worldwide.

Disclaimer:

This page is intended for general informational and corporate communications purposes and is not intended for, nor should it be construed as, providing medical advice, diagnosis, treatment recommendations, or promotional content regarding any prescription product. Information shared on this page should not be used as a substitute for consultation with a qualified healthcare professional.

Novugen does not endorse, verify, or assume responsibility for user-generated content posted on this page. We reserve the right to remove comments or other content that is unlawful, misleading, defamatory, offensive, or otherwise inconsistent with applicable policies or regulatory requirements.